Silexion Therapeutics Corp (SLXN)
NASDAQ: SLXN · Real-Time Price · USD
0.8100
-0.0040 (-0.49%)
At close: Jul 8, 2025, 4:00 PM
0.8317
+0.0217 (2.68%)
After-hours: Jul 8, 2025, 7:39 PM EDT
Silexion Therapeutics Market Cap
Silexion Therapeutics has a market cap or net worth of $6.82 million as of July 8, 2025. Its market cap has decreased by -84.55% in one year.
Market Cap
6.82M
Enterprise Value
10.12M
1-Year Change
-84.55%
Ranking
Category
Stock Price
0.81
Market Cap Chart
Since April 7, 2021, Silexion Therapeutics's market cap has decreased from $148.55M to $6.82M, a decrease of -95.41%. That is a compound annual growth rate of -51.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2025 | 6.85M | 112.57% |
| Dec 31, 2024 | 3.22M | -92.33% |
| Dec 21, 2023 | 41.99M | -71.93% |
| Dec 30, 2022 | 149.59M | 4.03% |
| Dec 31, 2021 | 143.80M | -3.20% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 700.84B |
| Johnson & Johnson | 375.37B |
| AbbVie | 334.34B |
| Novo Nordisk | 316.33B |
| UnitedHealth Group | 279.90B |
| Novartis AG | 242.35B |
| Abbott Laboratories | 233.90B |
| AstraZeneca | 218.65B |